CONIFER, CO--(MARKET WIRE)--Aug 15, 2007 -- Xpention Genetics, Inc. (OTC BB:XPNG.OB - News) has released the findings contained in the Final Report for the Phase I: Development of Immunological Test for Early Detection of Canine Cancers from The University of Texas Health Science Center at San Antonio (UTHSCSA) research team (full report may be viewed with the Company's recent filing at www.sec.gov) as well as preliminary results from its third party validation study.
